These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 28072395)
1. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer. Zhong H; Siddiqui SM; Movsas B; Chetty IJ Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395 [TBL] [Abstract][Full Text] [Related]
2. Adaptive radiotherapy for NSCLC patients: utilizing the principle of energy conservation to evaluate dose mapping operations. Zhong H; Chetty IJ Phys Med Biol; 2017 Jun; 62(11):4333-4345. PubMed ID: 28475493 [TBL] [Abstract][Full Text] [Related]
3. Utilization of a hybrid finite-element based registration method to quantify heterogeneous tumor response for adaptive treatment for lung cancer patients. Sharifi H; Zhang H; Bagher-Ebadian H; Lu W; Ajlouni MI; Jin JY; Kong FS; Chetty IJ; Zhong H Phys Med Biol; 2018 Mar; 63(6):065017. PubMed ID: 29480158 [TBL] [Abstract][Full Text] [Related]
4. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration. Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391 [TBL] [Abstract][Full Text] [Related]
5. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy. Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676 [TBL] [Abstract][Full Text] [Related]
7. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients. Duffton A; Harrow S; Lamb C; McJury M Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681 [TBL] [Abstract][Full Text] [Related]
8. An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy. Zhong H; Wen N; Gordon JJ; Elshaikh MA; Movsas B; Chetty IJ Phys Med Biol; 2015 Apr; 60(7):2837-51. PubMed ID: 25775937 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 4-dimensional computed tomography to 4-dimensional cone-beam computed tomography deformable image registration for lung cancer adaptive radiation therapy. Balik S; Weiss E; Jan N; Roman N; Sleeman WC; Fatyga M; Christensen GE; Zhang C; Murphy MJ; Lu J; Keall P; Williamson JF; Hugo GD Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):372-9. PubMed ID: 23462422 [TBL] [Abstract][Full Text] [Related]
10. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase. Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649 [TBL] [Abstract][Full Text] [Related]
11. Lung sparing and dose escalation in a robust-inspired IMRT planning method for lung radiotherapy that accounts for intrafraction motion. McCann C; Purdie T; Hope A; Bezjak A; Bissonnette JP Med Phys; 2013 Jun; 40(6):061705. PubMed ID: 23718584 [TBL] [Abstract][Full Text] [Related]
12. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699 [TBL] [Abstract][Full Text] [Related]
13. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer. Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698 [TBL] [Abstract][Full Text] [Related]
14. Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer. Guckenberger M; Kavanagh A; Partridge M Strahlenther Onkol; 2012 Oct; 188(10):894-900. PubMed ID: 22933031 [TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study. Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F; Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706 [TBL] [Abstract][Full Text] [Related]
16. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601 [TBL] [Abstract][Full Text] [Related]